Louis M. Weiner, MD
Why Personalized Medicine is the Only Way: Targeting the EGFR pathway

 

Louis M. Weiner, MD, is director of the Georgetown Lombardi Comprehensive Cancer Center. He earned his bachelor degree in biology with honors from the University of Pennsylvania and his medical degree from Mount Sinai School of Medicine at New York University. After completing his internship, residency, and service as chief medical resident at the University of Vermont’s Medical Center Hospital, he held clinical and research fellowships in hematology and oncology at Tufts University School of Medicine in Boston.

Prior to joining Lombardi, Weiner served as chairman of the Medical Oncology Department and vice president for Translational Research at Fox Chase Cancer Center in Philadelphia, PA. He held an endowed chair in medical science and was the driving force behind developing an immunotherapy laboratory and clinical programs, as well as establishing the Center’s medical oncology fellowship program. Weiner also served as professor in the Department of Medicine at Temple University School of Medicine.

As Director of the Lombardi Comprehensive Cancer Center, Chair of the Department of Oncology, Associate Vice President of Georgetown University Medical Center, and Clinical Director of Cancer Services at Georgetown University Hospital, Weiner is responsible for the operation and development of the cancer center, including its educational, research and clinical missions. In his role as Clinical Director of Cancer Services at Georgetown University Hospital, Weiner also leads the clinical operation of the Medical Oncology group. Weiner is known for his laboratory and clinical research focusing on new therapeutic approaches that mobilize the patient’s immune system to fight cancer using monoclonal antibodies – laboratory–crafted proteins designed to recognize specific cancer cells.

« Previous Speaker | Next Speaker »